Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease

Further Publications Immunology

Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases-a systematic literature review informing the 2024 update of an international expert consensus statement

Ann Rheum Dis

Konzett V, Smolen JS, Nash P, Aletaha D, Winthrop K, Dörner T, Fleischmann R, Tanaka Y, Primdahl J, Baraliakos X, McInnes IB, Trauner M, Sattar N, de Wit M, Schoones JW, Kerschbaumer A

doi: 10.1016/j.ard.2025.01.023

Rheumatoid Arthritis

Gastrointestinal perforation as a safety concern among patients with rheumatoid arthritis on Janus kinase inhibitor therapy: A systematic review and network meta-analysis

Arthritis Care Res (Hoboken)

Sathapanasiri T, Meraz M, Mokri H, Veettil S, Wijarnpreecha K, Schlesinger N, Kavanaugh A, Chaiyakunapruk N

doi: 10.1002/acr.25554

Further Publications Immunology

Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases-a systematic literature review informing the 2024 update of an international expert consensus statement

Ann Rheum Dis

Konzett V, Smolen JS, Nash P, Winthrop K, Aletaha D, Dörner T, Fleischmann R, Tanaka Y, Primdahl J, Baraliakos X, McInnes IB, Trauner M, Sattar N, de Wit M, W Schoones J, Kerschbaumer A

doi: 10.1016/j.ard.2025.01.024

Rheumatoid Arthritis

Effectiveness of janus kinase inhibitors compared with biologic disease modifying anti-rheumatic drugs on pain reduction in rheumatoid arthritis: Results from a nationwide Swedish cohort study

Arthritis Rheumatol

Eberhard A, Di Giuseppe D, Askling J, Bergman S, Bower H, Chatzidionysiou K, Forsblad-d'Elia H, Kastbom A, Olofsson T, Frisell T, Turesson C

doi: 10.1002/art.43014

Autoimmune Disease

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives

J Autoimmun

Wang P, Yuksel M, Gabeta S, Graham J, Hussain M, Blackmore LJ, Huang X, Hadzic D, Samyn M, Grammatikopoulos T, Heneghan M, Liberal R, Longhi MS, Mieli-Vergani G, Vergani D, Ma Y

doi: 10.1016/j.jaut.2025.103436

Rheumatoid Arthritis

Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK-pot" study)

Arthritis Rheumatol

Aymon R, Mongin D, Guemara R, Salis Z, Askling J, Choquette D, Codreanu C, Di Giuseppe D, Flouri I, Huschek D, Hyrich KL, Iannone F, Kvien TK, Leeb BF, Nordström D, Otero-Varela L, Pavelka K, Pombo-Suarez M, Rodrigues A, Rotar Z, Sidiropoulos P, Provan SA, Strangfeld A, Nina T, Zavada J, Kearsley-Fleet L, Courvoisier DS, Finckh A, Lauper K

doi: 10.1002/art.43188

Autoimmune Disease

Primary Cesarean delivery and future risk of maternal autoimmune disease: A population-based cohort study

J Autoimmun

Scime NV, Grandi SM, De Vera MA, Dennis CL, Boblitz A, Brown HK

doi: 10.1016/j.jaut.2025.103370

Melanoma and Skin Cancer

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

JAMA Dermatol

Ran NA, Granger EE, Brodland DG, Cañueto J, Carr DR, Carter JB, Carucci JA, Hirotsu KE, Koyfman SA, Mangold AR, Girardi FM, Shahwan KT, Srivastava D, Vidimos AT, Willenbrink TJ, Wysong A, Ruiz ES

doi: 10.1001/jamadermatol.2025.0128

Further Publications Rheumatology

Risk factors of COVID-19 related hospitalization of pediatric patients with rheumatic diseases: a systematic review and meta-analysis

Rheumatology (Oxford)

Zhao Q, Wallace B, Ronis T, Jung L

doi: 10.1093/rheumatology/keae664

Related content

Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases-a systematic literature review informing the 2024 update of an international expert consensus statement

Gastrointestinal perforation as a safety concern among patients with rheumatoid arthritis on Janus kinase inhibitor therapy: A systematic review and network meta-analysis

Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases-a systematic literature review informing the 2024 update of an international expert consensus statement

Effectiveness of janus kinase inhibitors compared with biologic disease modifying anti-rheumatic drugs on pain reduction in rheumatoid arthritis: Results from a nationwide Swedish cohort study

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives

Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK-pot" study)

Primary Cesarean delivery and future risk of maternal autoimmune disease: A population-based cohort study

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

Risk factors of COVID-19 related hospitalization of pediatric patients with rheumatic diseases: a systematic review and meta-analysis